Donald Trump’s man in London reiterated the US president’s demands for the UK to pay pharmaceutical companies more money.

I know how destructive unchecked addiction can be. All the victims of the ongoing opioid crisis do, too. And this is about more than addiction — as when rare but real cases of myocarditis appeared in ...

Pharmaceutical companies are better positioned to understand what information physicians want—and how to generate it quickly ...

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

Ironically enough, his initial downfall had nothing to do with Daraprim. Soon after he became infamous, federal prosecutors ...

But last week, those words took on the force of law. On Tuesday, Texas Attorney General Ken Paxton filed a lawsuit against ...

Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...

During the government shutdown, public health experts talked political and monetary hurdles, and fostering community amid ...

Localized supply chains are crucial for mitigating geopolitical risks and ensuring operational continuity in the biopharmaceutical sector. Regulatory harmonization enhances access to medicines, ...

Bayer and BI have reported broadly similar efficacy outcomes for sevabertinib and Hernexeos in HER2-mutant NSCLC.

A collaborative team led by psychiatrist Theodore D. Satterthwaite and postdoctoral fellow Golia Shafiei of the University of Pennsylvania has developed Reproducible Brain Charts, a large-scale, open ...

Out Nov. 3, In Waves and War focuses on a group of U.S. Navy SEALS who take Ibogaine, derived from a shrub native to Central ...